ArticleJournal of personalized medicine2023

Development and Validation of a Prognostic Risk Model Based on Nature Killer Cells for Serous Ovarian Cancer.

Chengxi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.